Skip to content

Clinical trials

Phase 3 Endometrial Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 3 Country / region: Germany Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20131
20161
20183
20191
20201
20212
20221
20232
20241
20256

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting7
Recruiting7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC5
AstraZeneca3
European Organisation for Research and Treatment of Cancer - EORTC2
Karyopharm Therapeutics Inc2
Leiden University Medical Center2
AEterna Zentaris1
BioNTech SE1
Daiichi Sankyo1
Eisai Inc.1
Genmab1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms22
Neoplasms4
Uterine Neoplasms3
Uterine Cervical Neoplasms2
Fibrosarcoma1
Genital Diseases1
Hemangiosarcoma1
Histiocytoma, Malignant Fibrous1
Infections1
Kidney Neoplasms1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.